405 related articles for article (PubMed ID: 31793874)
1. Burden of disease: Prevalence and incidence of endstage renal disease in Middle Eastern countries.
Shaheen FAM; Al-Attar B; Ahmad MK; Follero PM
Clin Nephrol; 2020; 93(1):120-123. PubMed ID: 31793874
[TBL] [Abstract][Full Text] [Related]
2. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
3. Burden of disease: prevalence and incidence of ESRD in Latin America.
Gonzalez-Bedat M; Rosa-Diez G; Pecoits-Filho R; Ferreiro A; García-García G; Cusumano A; Fernandez-Cean J; Noboa O; Douthat W
Clin Nephrol; 2015; 83(7 Suppl 1):3-6. PubMed ID: 25725232
[TBL] [Abstract][Full Text] [Related]
4. Renal replacement therapy in Latin American end-stage renal disease.
Rosa-Diez G; Gonzalez-Bedat M; Pecoits-Filho R; Marinovich S; Fernandez S; Lugon J; Poblete-Badal H; Elgueta-Miranda S; Gomez R; Cerdas-Calderon M; Almaguer-Lopez M; Freire N; Leiva-Merino R; Rodriguez G; Luna-Guerra J; Bochicchio T; Garcia-Garcia G; Cano N; Iron N; Cuero C; Cuevas D; Tapia C; Cangiano J; Rodriguez S; Gonzalez H; Duro-Garcia V
Clin Kidney J; 2014 Aug; 7(4):431-436. PubMed ID: 25349696
[TBL] [Abstract][Full Text] [Related]
5. End-stage renal care in developing countries: the India experience.
Jha V
Ren Fail; 2004 May; 26(3):201-8. PubMed ID: 15354966
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
Hruskova Z; Pippias M; Stel VS; Abad-Díez JM; Benítez Sánchez M; Caskey FJ; Collart F; De Meester J; Finne P; Heaf JG; Magaz A; Palsson R; Reisæter AV; Salama AD; Segelmark M; Traynor JP; Massy ZA; Jager KJ; Tesar V
Am J Kidney Dis; 2019 Feb; 73(2):184-193. PubMed ID: 30122544
[TBL] [Abstract][Full Text] [Related]
7. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
McDonald SP; Russ GR; Kerr PG; Collins JF;
Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
[TBL] [Abstract][Full Text] [Related]
8. Renal Replacement Therapy in Children in Lithuania: Challenges, Trends, and Outcomes.
Viršilas E; Čerkauskienė R; Masalskienė J; Rudaitis Š; Dobilienė D; Jankauskienė A
Medicina (Kaunas); 2018 Nov; 54(5):. PubMed ID: 30400223
[No Abstract] [Full Text] [Related]
9. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K;
Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003
[TBL] [Abstract][Full Text] [Related]
10. The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival.
Goldfarb-Rumyantzev AS; Hurdle JF; Scandling JD; Baird BC; Cheung AK
Am J Kidney Dis; 2005 Sep; 46(3):537-49. PubMed ID: 16129217
[TBL] [Abstract][Full Text] [Related]
11. Ten-years trends in renal replacement therapy for end-stage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registry.
Vigneau C; Kolko A; Stengel B; Jacquelinet C; Landais P; Rieu P; Bayat S; Couchoud C;
Nephrol Ther; 2017 Jun; 13(4):228-235. PubMed ID: 28161264
[TBL] [Abstract][Full Text] [Related]
12. The essential of 2012 results from the French Renal Epidemiology and Information Network (REIN) ESRD registry.
Lassalle M; Ayav C; Frimat L; Jacquelinet C; Couchoud C;
Nephrol Ther; 2015 Apr; 11(2):78-87. PubMed ID: 25457107
[TBL] [Abstract][Full Text] [Related]
13. Differences in renal registries between the Balkans and Western Europe.
Stojceva-Taneva O; Selim GJ; Zafirovska K; Polenakovic M
Prilozi; 2006 Dec; 27(2):37-47. PubMed ID: 17211290
[TBL] [Abstract][Full Text] [Related]
14. Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry.
Chesnaye N; Bonthuis M; Schaefer F; Groothoff JW; Verrina E; Heaf JG; Jankauskiene A; Lukosiene V; Molchanova EA; Mota C; Peco-Antić A; Ratsch IM; Bjerre A; Roussinov DL; Sukalo A; Topaloglu R; Van Hoeck K; Zagozdzon I; Jager KJ; Van Stralen KJ;
Pediatr Nephrol; 2014 Dec; 29(12):2403-10. PubMed ID: 25039018
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the timing of initiation of renal replacement therapy and choice of modality in children with end-stage kidney disease.
Favel K; Dionne JM
Pediatr Nephrol; 2020 Jan; 35(1):145-151. PubMed ID: 31654222
[TBL] [Abstract][Full Text] [Related]
16. End stage renal disease in Brunei Darussalam - report from the first Brunei Dialysis Transplant Registry (BDTR).
Tan J
Ren Fail; 2013 Sep; 35(8):1101-4. PubMed ID: 23879396
[TBL] [Abstract][Full Text] [Related]
17. Incidence of end stage renal disease on renal replacement therapy in Nepal.
Hada R; Khakurel S; Agrawal RK; Kafle RK; Bajracharya SB; Raut KB
Kathmandu Univ Med J (KUMJ); 2009; 7(27):301-5. PubMed ID: 20071881
[TBL] [Abstract][Full Text] [Related]
18. Kidney transplantation and other methods of renal replacement therapy in children: 30 years of observations in one center.
Medyńska A; Kiliś-Pstrusińska K; Makulska I; Zwolińska D
Adv Clin Exp Med; 2020 May; 29(5):611-613. PubMed ID: 32469165
[TBL] [Abstract][Full Text] [Related]
19. Overview: end-stage renal disease in the developing world.
Barsoum RS
Artif Organs; 2002 Sep; 26(9):737-46. PubMed ID: 12197924
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
